UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 29, 2013
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission File Number: 000-10030
APPLE INC.
(Exact name of registrant as specified in its charter)
California
94-2404110
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer Identification No.)
1 Infinite Loop
Cupertino, California
95014
(Address of principal executive offices)
(Zip Code)
Registrant s telephone number, including area code: (408) 996-1010
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes No
Indicate by check mark whether the registrant has submitted electronically
and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the
registrant was required to submit and post such files).
Yes No
Indicate by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
(Do not check if a smaller reporting company)
Smaller reporting company
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act).
Yes No
908,497,000 shares of common stock issued and outstanding as of July 12, 2013
PART I. FINANCIAL INFORMATION
Item 1.
Financial Statements
APPLE INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(In millions, except number of shares which are reflected in thousands and per share amounts)
Three Months Ended
Nine Months Ended
June 29,
2013
June 30,
2012
June 29,
2013
June 30,
2012
Net sales
35,323
35,023
133,438
120,542
Cost of sales
22,299
20,029
83,005
66,281
Gross margin
13,024
14,994
50,433
54,261
Operating expenses:
Research and development
1,178
876
3,307
2,475
Selling, general and administrative
2,645
2,545
8,157
7,489
Total operating expenses
3,823
3,421
11,464
9,964
Operating income
9,201
11,573
38,969
44,297
Other income/(expense), net
234
288
1,043
573
Income before provision for income taxes
9,435
11,861
40,012
44,870
Provision for income taxes
2,535
3,037
10,487
11,360
Net income
6,900
8,824
29,525
33,510
Earnings per share:
Basic
7.51
9.42
31.67
35.89
Diluted
7.47
9.32
31.44
35.48
Shares used in computing earnings per share:
Basic
918,618
936,596
932,388
933,672
Diluted
924,265
947,059
939,172
944,440
Cash dividends declared per common share
3.05
8.35
See accompanying Notes to Condensed Consolidated Financial Statements.
APPLE INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
(In millions)
Three Months Ended
Nine Months Ended
June 29,
2013
June 30,
2012
June 29,
2013
June 30,
2012
Net income
6,900
8,824
29,525
33,510
Other comprehensive (loss)/income:
Change in foreign currency translation, net of tax
(100
(91
(177
(88
Change in unrecognized gains/losses on derivative instruments:
Change in fair value of derivatives, net of tax
188
150
791
216
Adjustment for net (gains)/losses realized and included in net income, net of tax
(357
(54
(203
(305
Total change in unrecognized gains/losses on derivative instruments, net of tax
(169
96
588
(89
Change in unrealized gains/losses on marketable securities:
Change in fair value of marketable securities, net of tax
(883
22
(1,001
325
Adjustment for net (gains)/losses realized and included in net income, net of tax
(46
(19
(143
(59
Total change in unrealized gains/losses on marketable securities, net of tax
(929
(1,144
266
Total other comprehensive (loss)/income
(1,198
(733
89
Total comprehensive income
5,702
8,832
28,792
33,599
See accompanying Notes to Condensed Consolidated Financial Statements.
APPLE INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(In millions, except number of shares which are reflected in thousands)
June 29,
2013
September 29,
2012
ASSETS:
Current assets:
Cash and cash equivalents
11,248
10,746
Short-term marketable securities
31,358
18,383
Accounts receivable, less allowances of $104 and $98, respectively
8,839
10,930
Inventories
1,697
791
Deferred tax assets
3,193
2,583
Vendor non-trade receivables
4,614
7,762
Other current assets
7,270
6,458
Total current assets
68,219
57,653
Long-term marketable securities
104,014
92,122
Property, plant and equipment, net
16,327
15,452
Goodwill
1,522
1,135
Acquired intangible assets, net
4,353
4,224
Other assets
5,421
5,478
Total assets
199,856
176,064
LIABILITIES AND SHAREHOLDERS EQUITY:
Current liabilities:
Accounts payable
15,516
21,175
Accrued expenses
13,470
11,414
Deferred revenue
7,333
5,953
Total current liabilities
36,319
38,542
Deferred revenue non-current
2,672
2,648
Long-term debt
16,958
Other non-current liabilities
20,553
16,664
Total liabilities
76,502
57,854
Commitments and contingencies
Shareholders equity:
Common stock, no par value; 1,800,000 shares authorized; 908,442 and 939,208 shares issued and outstanding,
respectively
19,024
16,422
Retained earnings
104,564
101,289
Accumulated other comprehensive (loss)/income
(234
499
Total shareholders equity
123,354
118,210
Total liabilities and shareholders equity
199,856
176,064
See accompanying Notes to Condensed Consolidated Financial Statements.
APPLE INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(In millions)
Nine Months Ended
June 29,
2013
June 30,
2012
Cash and cash equivalents, beginning of the period
10,746
9,815
Operating activities:
Net income
29,525
33,510
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
4,974
2,296
Share-based compensation expense
1,698
1,292
Deferred income tax expense
2,524
4,066
Changes in operating assets and liabilities:
Accounts receivable, net
2,091
(2,278
Inventories
(906
(346
Vendor non-trade receivables
3,148
(293
Other current and non-current assets
484
(3,238
Accounts payable
(4,740
2,450
Deferred revenue
1,404
2,575
Other current and non-current liabilities
3,556
1,686
Cash generated by operating activities
43,758
41,720
Investing activities:
Purchases of marketable securities
(122,681
(121,091
Proceeds from maturities of marketable securities
13,963
10,344
Proceeds from sales of marketable securities
81,734
73,140
Payments made in connection with business acquisitions, net
(443
(350
Payments for acquisition of property, plant and equipment
(6,210
(4,834
Payments for acquisition of intangible assets
(560
(1,067
Other
(188
(56
Cash used in investing activities
(34,385
(43,914
Financing activities:
Proceeds from issuance of common stock
335
433
Excess tax benefits from equity awards
644
1,036
Taxes paid related to net share settlement of equity awards
(1,001
(1,145
Dividends and dividend equivalent rights paid
(7,795
Repurchase of common stock
(17,950
Proceeds from issuance of long-term debt, net
16,896
Cash (used in)/generated by financing activities
(8,871
324
Increase/(decrease) in cash and cash equivalents
502
(1,870
Cash and cash equivalents, end of the period
11,248
7,945
Supplemental cash flow disclosure:
Cash paid for income taxes, net
7,188
5,901
See accompanying Notes to Condensed Consolidated Financial Statements.
Apple Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 Summary of Significant Accounting Policies
Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs,
manufactures, and markets mobile communication and media devices, personal computers, and portable digital music players, and sells a variety of related software, services, peripherals, networking solutions, and third-party digital content and
applications. The Company sells its products worldwide through its retail stores, online stores, and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the
Company sells a variety of third-party iPhone, iPad, Mac, and iPod compatible products, including application software, and various accessories through its online and retail stores. The Company sells to consumers, small and mid-sized businesses, and
education, enterprise and government customers.
Basis of Presentation and Preparation
The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions
have been eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ( GAAP ) requires management to make estimates and assumptions that affect the
amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Certain prior period amounts in the condensed consolidated financial statements and notes
thereto have been reclassified to conform to the current period s presentation.
These condensed consolidated financial
statements and accompanying notes should be read in conjunction with the Company s annual consolidated financial statements and the notes thereto for the fiscal year ended September 29, 2012, included in its Annual Report on Form 10-K (the
2012 Form 10-K ). The Company s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. The Company s fiscal year 2013 will include 52 weeks, whereas fiscal year 2012 included 53 weeks. An additional
week was included in the first quarter of 2012 to realign the Company s fiscal quarters more closely to calendar quarters. Unless otherwise stated, references to particular years, quarters, months or periods refer to the Company s fiscal
years ended in September and the associated quarters, months or periods of those fiscal years.
During the first quarter of
2013, the Company adopted amended accounting standards that changed the presentation of comprehensive income. These standards increased the prominence of other comprehensive income ( OCI ) by eliminating the option to present components of
OCI as part of the statement of changes in shareholders equity and required the components of OCI to be presented either in a single continuous statement of comprehensive income or in two consecutive statements. The amended accounting
standards only impacted the financial statement presentation of OCI and did not change the components that are recognized in net income or OCI; accordingly, the adoption had no impact on the Company s financial position or results of
operations.
Earnings Per Share
Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share
is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been
outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the Company s employee stock purchase plan and unvested restricted stock units
( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the
Company s common stock can result in a greater dilutive effect from potentially dilutive securities.
The following table shows the computation of basic and diluted earnings per share for the
three- and nine-month periods ended June 29, 2013 and June 30, 2012 (in thousands, except net income in millions and per share amounts):
Three Months Ended
Nine Months Ended
June 29,
2013
June 30,
2012
June 29,
2013
June 30,
2012
Numerator:
Net income
6,900
8,824
29,525
33,510
Denominator:
Weighted-average shares outstanding
918,618
936,596
932,388
933,672
Effect of dilutive securities
5,647
10,463
6,784
10,768
Weighted-average diluted shares
924,265
947,059
939,172
944,440
Basic earnings per share
7.51
9.42
31.67
35.89
Diluted earnings per share
7.47
9.32
31.44
35.48
Potentially dilutive securities representing 5.1 million and 4.4 million shares of common stock
for the three- and nine-month periods ended June 29, 2013, were excluded from the computation of diluted earnings per share because their effect would have been antidilutive. The number of potentially dilutive securities excluded from the
computation of diluted earnings per share because their effect would have been antidilutive was not significant for the three- and nine-month periods ended June 30, 2012.
Note 2 Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following tables show the Company s cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category
recorded as cash and cash equivalents or short- or long-term marketable securities as of June 29, 2013 and September 29, 2012 (in millions):
June 29, 2013
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
6,196
6,196
6,196
Level 1 (a):
Money market funds
1,887
1,887
1,887
Mutual funds
3,974
(206
3,768
3,768
Subtotal
5,861
(206
5,655
1,887
3,768
Level 2 (b):
U.S. Treasury securities
31,329
11
(84
31,256
327
11,717
19,212
U.S. agency securities
18,200
(78
18,131
450
3,579
14,102
Non-U.S. government securities
4,899
29
(156
4,772
390
4,382
Certificates of deposit and time deposits
2,103
2,103
1,023
423
657
Commercial paper
2,996
2,996
1,365
1,631
Corporate securities
54,285
236
(379
54,142
8,920
45,222
Municipal securities
6,314
36
(40
6,310
915
5,395
Mortgage- and asset-backed securities
15,140
17
(98
15,059
15
15,044
Subtotal
135,266
338
(835
134,769
3,165
27,590
104,014
Total
147,323
338
(1,041
146,620
11,248
31,358
104,014
September 29, 2012
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
3,109
3,109
3,109
Level 1 (a):
Money market funds
1,460
1,460
1,460
Mutual funds
2,385
79
(2
2,462
2,462
Subtotal
3,845
79
(2
3,922
1,460
2,462
Level 2 (b):
U.S. Treasury securities
20,088
21
(1
20,108
2,608
3,525
13,975
U.S. agency securities
19,540
58
(1
19,597
1,460
1,884
16,253
Non-U.S. government securities
5,483
183
(2
5,664
84
1,034
4,546
Certificates of deposit and time deposits
2,189
2,191
1,106
202
883
Commercial paper
2,112
2,112
909
1,203
Corporate securities
46,261
568
(8
46,821
10
7,455
39,356
Municipal securities
5,645
74
5,719
618
5,101
Mortgage- and asset-backed securities
11,948
66
(6
12,008
12,008
Subtotal
113,266
972
(18
114,220
6,177
15,921
92,122
Total
120,220
1,051
(20
121,251
10,746
18,383
92,122
(a)
The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities.
(b)
The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and
liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
The net unrealized losses as of June 29, 2013 and net unrealized gains as of September 29, 2012
are related primarily to long-term marketable securities. The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipation of credit deterioration and
duration management. The net realized gains or losses recognized by the Company related to such sales were not significant during the three- and nine-month periods ended June 29, 2013 and June 30, 2012. The maturities of the Company s
long-term marketable securities generally range from one to five years.
As of June 29, 2013 and September 29, 2012,
gross unrealized losses related to individual securities that had been in a continuous loss position for 12 months or longer were not significant.
As of June 29, 2013, the Company considered the declines in market value of its marketable securities investment portfolio to be temporary in nature and did not consider any of its investments
other-than-temporarily impaired. The Company typically invests in highly-rated securities, and its investment policy generally limits the amount of credit exposure to any one issuer. The policy requires investments generally to be investment grade,
with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When evaluating an investment for other-than-temporary impairment, the Company
reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, changes in market interest rates, and the Company s intent to sell, or
whether it is more likely than not it will be required to sell, the investment before recovery of the investment s cost basis. During the three- and nine-month periods ended June 29, 2013 and June 30, 2012, the Company did not
recognize any significant impairment charges.
Derivative Financial Instruments
The Company uses derivatives to partially offset its business exposure to foreign currency and interest rate risk. The Company may enter
into forward contracts, option contracts, swaps, or other derivative instruments to offset some of the risk on expected future cash flows, on net investments in certain foreign subsidiaries, and on certain existing assets and liabilities.
To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company s
subsidiaries whose functional currency is the U.S. dollar hedge a portion of forecasted foreign currency revenue. The Company s subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may hedge a portion
of forecasted inventory purchases not denominated in the subsidiaries functional currencies. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases generally up to six
months.
To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates,
the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates.
To help protect against adverse fluctuations in interest rates, the Company may enter into interest rate swaps, options, or other
instruments to offset a portion of the changes in income or expense due to fluctuations in interest rates.
The Company may
also enter into foreign currency forward and option contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. However, the
Company may choose not to hedge certain foreign currency exchange exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no
assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange rates.
The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The Company s accounting treatment of these instruments is based on whether the instruments are
designated as hedge or non-hedge instruments. The effective portions of cash flow hedges are recorded in accumulated other comprehensive income ( AOCI ) until the hedged item is recognized in earnings. The effective portions of net
investment hedges are recorded in OCI as a part of the cumulative translation adjustment. The ineffective portions of cash flow hedges and net investment hedges are recorded in other income and expense. Derivatives that are not designated as hedging
instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates.
The Company had a net deferred gain of $348 million and a net deferred loss of $240 million associated with cash flow hedges, net of
taxes, recorded in AOCI as of June 29, 2013 and September 29, 2012, respectively. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the
related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses
associated with cash flow hedges of interest income or expense are recognized as a component of other income/(expense), net in the same period as the related income or expense is recognized. The majority of the Company s hedged foreign currency
transactions and hedged interest rate transactions as of June 29, 2013 are expected to occur within six months and five years, respectively.
Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within
a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified immediately into other income and expense. Any subsequent changes in fair value of such derivative instruments are
reflected in other income and expense unless they are re-designated as hedges of other transactions. The Company did not recognize any significant net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during
the three- and nine-month periods ended June 29, 2013 and June 30, 2012.
The Company s unrealized net gains and losses on net investment hedges, included in the
cumulative translation adjustment account of AOCI, were not significant as of June 29, 2013 and September 29, 2012. The ineffective portions of and amounts excluded from the effectiveness test of net investment hedges are recorded in other
income and expense.
The gain/loss recognized in other income and expense for foreign currency forward and option contracts
not designated as hedging instruments was not significant during the three- and nine-month periods ended June 29, 2013 and June 30, 2012, respectively. These amounts represent the net gain or loss on the derivative contracts and do not
include changes in the related exposures, which generally offset a portion of the gain or loss on the derivative contracts.
The following table shows the notional principal amounts of the Company s outstanding derivative instruments and credit risk amounts
associated with outstanding or unsettled derivative instruments as of June 29, 2013 and September 29, 2012 (in millions):
June 29, 2013
September 29, 2012
Notional
Principal
Credit Risk
Amounts
Notional
Principal
Credit Risk
Amounts
Instruments designated as accounting hedges:
Foreign exchange contracts
29,489
585
41,970
140
Interest rate contracts
3,000
69
Instruments not designated as accounting hedges:
Foreign exchange contracts
11,635
84
13,403
12
The notional principal amounts for outstanding derivative instruments provide one measure of the
transaction volume outstanding and do not represent the amount of the Company s exposure to credit or market loss. The credit risk amounts represent the Company s gross exposure to potential accounting loss on derivative instruments that
are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency or interest rates at each respective date. The Company s gross exposure on these transactions may be
further mitigated by collateral received from certain counterparties. The Company s exposure to credit loss and market risk will vary over time as a function of currency and interest rates. Although the table above reflects the notional
principal and credit risk amounts of the Company s derivative instruments, it does not reflect the gains or losses associated with the exposures and transactions that the instruments are intended to hedge. The amounts ultimately realized upon
settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.
The Company generally enters into master netting arrangements, which are designed to reduce credit risk by permitting net settlement of
transactions with the same counterparty. To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net fair value of certain financial instruments
fluctuates from contractually established thresholds. The Company presents its derivative assets and derivative liabilities at their gross fair values. As of June 29, 2013, the Company received $642 million of cash collateral related to the
derivative instruments under its collateral security arrangements, which were recorded as accrued expenses in the Condensed Consolidated Balance Sheet. As of September 29, 2012, the Company posted cash collateral related to the derivative
instruments under its collateral security arrangements of $278 million, which it recorded as other current assets in the Condensed Consolidated Balance Sheet. The Company did not have any derivative instruments with credit-risk related
contingent features that would require it to post additional collateral as of June 29, 2013 or September 29, 2012.
10
The following tables show the Company s derivative instruments at gross fair value as
reflected in the Condensed Consolidated Balance Sheets as of June 29, 2013 and September 29, 2012 (in millions):